Lv11
10 积分 2022-02-28 加入
Neutrophil diversity and plasticity in tumour progression and therapy
2小时前
待确认
Tumour-associated neutrophils in patients with cancer
2小时前
已完结
Engineering CD3/CD137 dual specificity into a DLL3-targeted T-cell engager enhances T-cell infiltration and efficacy against small cell lung cancer
7天前
已完结
T cell-engaging therapies — BiTEs and beyond
25天前
已完结
New immune cell engagers for cancer immunotherapy
25天前
已完结
Targeting overexpressed antigens in glioblastoma via CAR T cells with computationally designed high-affinity protein binders
27天前
已完结
RG6333 (CD19-CD28), a CD19-Targeted Affinity-Optimized CD28 Bispecific Antibody, Enhances and Prolongs the Anti-Tumor Activity of Glofitamab (CD20-TCB) in Preclinical Models
1个月前
已完结
RG6333 (CD19-CD28), a CD19-Targeted Affinity-Optimized CD28 Bispecific Antibody, Enhances and Prolongs the Anti-Tumor Activity of Glofitamab (CD20-TCB) in Preclinical Models
1个月前
已关闭
A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains
1个月前
已完结
An FDA oncology analysis of CD3 bispecific constructs and first-in-human dose selection
1个月前
已完结
皖公网安备34019202002308
